Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRIM24 | O15164 | 1/20 | 0.32 |
| ▸ | SALL4 | Q9UJQ4 | 1/20 | 0.32 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.32 |
| ▸ | HTR6 | P50406 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.30 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.30 |
| ▸ | RELA | Q04206 | 2/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7169500 | 0.97 | SALL4 (0.31) | TRIM24SALL4TRIM33HTR6CYP2A6 | |
| Hydrochloric Acid SCHEMBL7165108 | 0.97 | SALL4 (0.31) | TRIM24SALL4TRIM33HTR6CYP2A6 | |
| SCHEMBL3199427 | 0.81 | MAPT (0.37) | MAPTCYP1A2CYP2A6TSHR | |
| SCHEMBL7198080 | 0.76 | NISCH (0.30) | — | |
| Hydrochloric Acid SCHEMBL7169014 | 0.75 | NISCH (0.34) | — | |
| SCHEMBL9059241 | 0.72 | MAPT (0.37) | MAPTCYP1A2CYP2A6TSHR | |
| Iodide SCHEMBL28815180 | 0.70 | MAPT (0.38) | MAPTCYP1A2CYP2A6TSHR | |
| Bromide SCHEMBL28815167 | 0.70 | MAPT (0.38) | MAPTCYP1A2CYP2A6TSHR | |
| Hydrochloric Acid SCHEMBL28815114 | 0.70 | MAPT (0.38) | MAPTCYP1A2CYP2A6TSHR | |
| Hydrochloric Acid SCHEMBL7170194 | 0.68 | MAPT (0.33) | MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1153032-B1 | BIMETALLIC METALLOCENE CATALYST FOR ISOTACTIC POLYPROPYLENE POLYMERISATION | ATOFINA RES (BE) | 2003-04-02 | — | — | EP | claimed |
| US-6583243-B2 | Addition polymerization using metallocene catalyst | FINA RESEARCH, S.A. (BE) | 2003-06-24 | — | — | US | disclosed |
| US-6579822-B2 | Coordination polymerization catalyst | FINA RESEARCH, S.A. (BE) | 2003-06-17 | — | — | US | disclosed |
| EP-1153032-B1 | BIMETALLIC METALLOCENE CATALYST FOR ISOTACTIC POLYPROPYLENE POLYMERISATION | ATOFINA RES (BE) | 2003-04-02 | — | — | EP | disclosed |
| US-20020133034-A1 | Polyolefin production | RAZAVI ABBAS (BE) | 2002-09-19 | — | — | US | disclosed |
| US-20020120161-A1 | Polyolefin production | RAZAVI ABBAS (BE) | 2002-08-29 | — | — | US | disclosed |
| US-6407273-B1 | COORDINATION CATALYST | FINA RESEARCH, S.A. (BE) | 2002-06-18 | — | — | US | disclosed |
| EP-1010709-A1 | Metallocene compound and its use for polyolefin production | FINA RESEARCH S.A. (BE) | 2000-06-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020133034-A1 | Polyolefin production | SRRM2, CSE1L, CACNA1A | TRIM24 1089/4885SALL4 197/4885TRIM33 2929/4885 |
| US-20020120161-A1 | Polyolefin production | SRRM2, CSE1L, CACNA1A | TRIM24 998/4885SALL4 195/4885TRIM33 2723/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.